Browsing by Author Palumbo, Antonio

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2017Carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVORJoshua, Douglas; Chng, W-J; Dimopoulos, Meletios A; et al, Various; Facon, Thierry; Goldschmidt, Hartmut; Ludwig, Heinz; Moreau, Philippe; Niesvizky, R.; Palumbo, Antonio; Pour, Ludek; Central Clinical School: MedicineCarfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVOR, Leukemia, vol.31, 6, 2017,pp 1368-1374
2017Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR studyJoshua, Douglas; Chng, W-J; et al, Various; Facon, Thierry; Goldschmidt, Hartmut; Hajek, Roman; Ludwig, Heinz; Moreau, Philippe; Niesvizky, R.; Palumbo, Antonio; Pour, Ludek; Central Clinical School: MedicineImpact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR study, Leukemia, vol.31, 1, 2017,pp 115-122
2014International Myeloma Working Group recommendations for global myeloma careJoshua, Douglas; Dimopoulos, Meletios Athanassios; et al, Various; Gracia Sanz, Ramon; Hou, Jian; Lentzsch, Suzanne; Ludwig, H; Miguel, Jesus San; Ming Chen, W; Palumbo, Antonio; Powles, Ray; Central Clinical School: MedicineInternational Myeloma Working Group recommendations for global myeloma care, Leukemia, vol.28, 5, 2014,pp 981-992